S100a8/A9 proteins: critical regulators of inflammation in cardiovascular diseases
Open Access
- 8 August 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 11, 1394137
Abstract
Neutrophil hyperexpression is recognized as a key prognostic factor for inflammation and is closely related to the emergence of a wide range of cardiovascular disorders. In recent years, S100 calcium binding protein A8/A9 (S100A8/A9) derived from neutrophils has attracted increasing attention as an important warning protein for cardiovascular disease. This article evaluates the utility of S100A8/A9 protein as a biomarker and therapeutic target for diagnosing cardiovascular diseases, considering its structural features, fundamental biological properties, and its multifaceted influence on cardiovascular conditions including atherosclerosis, myocardial infarction, myocardial ischemia/reperfusion injury, and heart failure.Keywords
This publication has 85 references indexed in Scilit:
- COVID-19 immune features revealed by a large-scale single-cell transcriptome atlasCell, 2021
- Role of S100 proteins in health and diseaseBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2020
- Value of Neutrophil to Lymphocyte Ratio and Its Trajectory in Patients Hospitalized With Acute Heart Failure and Preserved Ejection FractionThe American Journal of Cardiology, 2020
- S100 proteins in obesity: liaisons dangereusesCellular and Molecular Life Sciences, 2019
- Targeting S100 Calcium-Binding Proteins with Small Molecule Inhibitors2019
- S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormoneJournal of Molecular Medicine, 2017
- S100A8/A9 regulates MMP-2 expression and invasion and migration by carcinoma cellsThe International Journal of Biochemistry & Cell Biology, 2014
- Beneficial effects of quinoline-3-carboxamide (ABR-215757) on atherosclerotic plaque morphology in S100A12 transgenic ApoE null miceAtherosclerosis, 2013
- Hypoxia and HIF‐1 increase S100A8 and S100A9 expression in prostate cancerInternational Journal of Cancer, 2012
- S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signalingBasic Research in Cardiology, 2012